会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • Real drink of water caltrop and its preparation
    • 实际饮用水及其制备
    • JPS59169479A
    • 1984-09-25
    • JP4346083
    • 1983-03-16
    • Hideo Sugi
    • SUGI HIDEO
    • A23L2/38A23F3/34
    • PURPOSE: To prepare a novel drink having a frangrance and flavor, by boiling seeds of water caltrop together with shells, drying, grinding, and roasting them.
      CONSTITUTION: For example, seeds of water caltrop together with shells are added to hot water, taken out and dried naturally by the sun. The seeds are ground by a crusher into about 1W10mm particle size, and roasted. When degree of roasting is low, the prepared drink is colored in light red brown, and has nice smell and good taste, and when degree of roasting is high, it is colored like coffee, has strong smell and slight bitterness.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:为了准备一种具有香味和风味的新鲜饮料,可以将水葫芦的种子与壳一起煮沸,干燥,研磨和烘焙。 构成:例如,将水rop,子与壳一起加入热水中,由太阳自然取出并干燥。 将种子用破碎机研磨成约1-10mm。 颗粒大小,并烘烤。 当焙烧程度低时,制成的饮料为浅红棕色,味道好,味道好,焙烧程度高,咖啡色,味道浓烈,味道轻微。
    • 4. 发明授权
    • Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2
inhibitor containing them
    • 二氨基三氟甲基吡啶化合物和含有它们的磷脂酶A2抑制剂
    • US5260320A
    • 1993-11-09
    • US921083
    • 1992-07-29
    • Takahiro HagaHideo SugiItaru ShigeharaShinji OdawaraSyuichi YotsuyaHirohiko KimuraKazuhiro Yamamoto
    • Takahiro HagaHideo SugiItaru ShigeharaShinji OdawaraSyuichi YotsuyaHirohiko KimuraKazuhiro Yamamoto
    • C07D213/75C07D213/76C07D401/12C07D405/12C07D409/12C07D413/12C07D417/12C07D453/02C07D495/04A61K31/44
    • C07D213/75C07D213/76C07D401/12C07D405/12C07D409/12C07D413/10C07D417/12C07D453/02C07D495/04
    • A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sup.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.
    • 式(I)的二氨基三氟甲基吡啶衍生物或其盐:其中X为-CW1R1,-COCOR2,-CW1NHCOR2,-C(= W1)W2R3或-CW1N(R4)R5,Y为烷基 ,-CW 3 R 6,-COCOR 7,-NHCOR 7,-C(= W3)W 4 R 8, - (NH)m SO 2 R 9, - (NH)m SO 2 OR 10或 - (NH)m SO 2 N(R 11)R 12,其中R 1,R 6和R 9各自 彼此独立,可以被取代的链状烃基,可以被取代的单环烃基,可以被取代的多环烃基,可以被取代的单环杂环基或可以被取代的多环杂环基 取代的,R 2和R 7各自独立地为可以被取代的烷基,可以被取代的烷氧基,可以被取代的苯基或可被取代的苯氧基,R 3,R 8和R 10各自为 彼此独立地是可以被取代的烷基,可以被取代的链烯基,可被取代的炔基,其中的环烷基 可被取代的苯基或可被取代的苄基,R 4,R 5,R 11和R 12各自彼此独立地是可以被取代的烷基,各自为W1,W2,W3和W4, 其彼此独立的是氧原子或硫原子,并且m为0或1,条件是其中X和Y之一是-COCF 2 X 1的组合,其中X 1是氢原子,卤素原子,烷基或卤代烷基 另一个是-COCF 2 X 2,其中X 2是氢原子,卤原子,烷基,卤代烷基或烷基羰基,或-COOX 3,其中X 3是可被取代的烷基或可被取代的苯基。
    • 5. 发明授权
    • Diaminotrifluoromethylpyridine derivatives and phospholipase A.sub.2
inhibitor containing them
    • 含有它们的二氨基三氟甲基吡啶衍生物和磷脂酶A2抑制剂
    • US5229403A
    • 1993-07-20
    • US723377
    • 1991-06-28
    • Takahiro HagaHideo SugiItaru ShigeharaShinji OdawaraSyuichi YotsuyaHirohiko KimuraKazuhiro Yamamoto
    • Takahiro HagaHideo SugiItaru ShigeharaShinji OdawaraSyuichi YotsuyaHirohiko KimuraKazuhiro Yamamoto
    • A61K31/4427A61P5/48A61P29/00C07D213/75C07D213/76C07D401/12C07D405/12C07D409/12C07D413/12C07D417/12C07D453/02C07D495/04
    • C07D213/75C07D213/76C07D401/12C07D405/12C07D409/12C07D413/10C07D413/12C07D417/12C07D453/02C07D495/04
    • A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1 (W.sup.2 W.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sub.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.
    • 式(I)的二氨基三氟甲基吡啶衍生物或其盐:其中X为-CW1R1,-COCOR2,-CW1NHCOR2,-C(= W1(W2W3或-CW1N(R4)R5,Y为烷基 ,-CW 3 R 6,-COCOR 7,-NHCOR 7,-C(= W 3)W 4 R 8, - (NH)m SO 2 R 9, - (NH)m SO 2 OR 10或 - (NH)m SO 2 N R 11)R 12,其中R 1,R 6和R 9 彼此独立地是可以被取代的链状烃基,可以被取代的单环烃基,可以被取代的多环烃基,可以被取代的单环杂环基或可以被取代的多环杂环基 相互独立的R 2和R 7各自为可被取代的烷基,可被取代的烷氧基,可被取代的烷氧基,可被取代的苯基或可被取代的苯氧基,R 3,R 8和R 10各自独立地 可以是可以被取代的烷基,可以被取代的链烯基,可被取代的炔基,其中的环烷基 可被取代的苯基或可被取代的苄基,R 4,R 5,R 11和R 12各自彼此独立地是可以被取代的烷基,各自为W1,W2,W3和W4, 其彼此独立的是氧原子或硫原子,并且m为0或1,条件是其中X和Y之一是-COCF 2 X 1的组合,其中X 1是氢原子,卤素原子,烷基或卤代烷基 另一个是-COCF 2 X 2,其中X 2是氢原子,卤原子,烷基,卤代烷基或烷基羰基,或-COOX 3,其中X 3是可被取代的烷基或可被取代的苯基。
    • 9. 发明授权
    • N-benzoyl urea compounds, antitumorous compositions containing them
    • N-苯甲酰脲化合物,含有它们的抗肿瘤组合物
    • US4863924A
    • 1989-09-05
    • US939025
    • 1986-12-08
    • Takahiro HagaNobutoshi YamadaHideo SugiToru KoyanagiHiroshi Okada
    • Takahiro HagaNobutoshi YamadaHideo SugiToru KoyanagiHiroshi Okada
    • C07D213/64A61K31/44A61K31/4402A61K31/4418A61K31/50A61K31/505A61P35/00C07D213/643C07D237/14C07D239/34
    • C07D213/643C07D237/14C07D239/34
    • An N-benzoyl urea compound having the formula: ##STR1## wherein X is a hydrogen atom, a halogen atom or a nitro group, n is an integer of from 1 to 3, and Q is ##STR2## wherein Y.sub.1 is an unsubstituted or substituted alkyl group, or an alkoxy or alkoxycarbonyl group with its alkyl moiety unsubstituted or substituted, Y.sub.2 is a hydrogen atom, a halogen atom, a nitro group, an unsubstituted or substituted alkyl group, or an alkoxy or alkoxycarbonyl group with its alkyl moiety unsubstituted or substituted, Z is a hydrogen atom, a halogen atom, a trifluoromethyl group or a nitro group, and each of A and B is .dbd.CH-- or a nitrogen atom, provided that one of A and B is .dbd.CH-- and the other is a nitrogen atom, with the provisos (1) that when Q is ##STR3## where when X is a hydrogen atom and Y.sub.1 is an alkyl group, Z is not a hydrogen atom, a halogen atom nor a trifluoromethyl group, and (2) that when Q is ##STR4## wherein A is a nitrogen atom and Y.sub.1 is a trifluoromethyl group, Y.sub.2 is other than a hydrogen atom.
    • 具有下式的N-苯甲酰脲化合物:其中X是氢原子,卤素原子或硝基,n是1至3的整数,Q是< IMAGE> 其中Y1是未取代或取代的烷基,或其烷基部分被未取代或取代的烷氧基或烷氧基羰基,Y2是氢原子,卤素原子,硝基,未取代或取代的烷基或烷氧基 或其烷基部分为未取代或取代的烷氧基羰基,Z为氢原子,卤素原子,三氟甲基或硝基,A和B各自为= CH-或氮原子,条件是A和 B是= CH-,另一个是氮原子,条件是(1)当Q是 + TR 时,当X是氢原子且Y1是烷基时,Z是 不是氢原子,卤素原子或三氟甲基,和(2)当Q是氮时,其中A是氮原子,Y 1是三氟甲基 堆,Y2不是氢原子。